Fycompa

This page shows the latest Fycompa news and features for those working in and with pharma, biotech and healthcare.

Germany planning to table pricing reforms 'by the summer'

Eisai did likewise for its epilepsy treatment Fycompa (perampanel).

Latest news

Eisai establishes neuroscience unit in Belgium and Luxembourg

The new unit will market the company's epilepsy drug Fycompa (perampanel), which it has been giving a rolling launch across the region. ... Fycompa indicated for the adjunctive treatment of partial onset seizures, with or without secondarily generalised
Eisai opens first office in Australia

Eisai opens first office in Australia. New Melbourne base to support marketing of Halaven and Fycompa. ... Fycompa is the first in a new class of treatment for partial onset seizures, the most common form of epilepsy.
Eisai "speechless" as G-BA denies price premium for Fycompa

Eisai "speechless" as G-BA denies price premium for Fycompa. But company has better news on cancer drug Halaven. ... Eisai's efforts to secure favourable pricing for its epilepsy drug Fycompa in Germany have hit the buffers once again.
Eisai backs competition to find star of epilepsy comic book

Epilepsy is a relative new area of focus for Eisai, whose treatment options include Fycompa (perampanel), which was launched in Europe in 2012.
Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

Eisai has issued a damning statement criticising Germany's healthcare watchdog IQWIG for not backing epilepsy drug Fycompa. ... IQWIG's recommendation will now be considered by the G-BA, which is expected to published a decision on Fycompa's use in

More from news
Approximately 13 fully matching, plus 11 partially matching documents found.

Latest Intelligence

Eisai: Bucking the trend with R&D growth

by adding a new solid dose global manufacturing line for its anti-epileptic medicine Fycompa. ... Fycompa was the first Eisai-developed epilepsy drug and it's “ a drug we can really differentiate”, says Hendler.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Client Services Director – Healthcare Advertising - London: Neg

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Delivery Manager/ Head of Delivery – Executive Search: Neg

Account Manager: £40, 000 - £45, 000 benefits

Editorial Director – Medical Education (MedComms): Neg

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Home based, Principal Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Business Unit Head, Medical Communications, London: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Senior Account Manager: Competitive salary commensurate with experience

Home based, Chief Medical Writer, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....